Fact check
“The Clear Labels Act was introduced earlier this year by Sens. Rick Scott, R-Fla., and Kirsten Gillibrand, D-N.Y.”
Reasoning
The claim is directly supported by several excerpts from ProPublica articles that name both senators as the bill's sponsors and note the timing of its introduction.
On confidence: Multiple primary sources from ProPublica explicitly state that the Clear Labels Act was introduced earlier this year by Sens. Rick Scott (R‑Fla.) and Kirsten Gillibrand (D‑N.Y.).
Important context
The Clear Labels Act is a bipartisan bill aimed at increasing transparency about drug manufacturing locations on prescription labels.
Evidence
Supporting (6)
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
their drugs were made is headed for a full Senate vote, but safety experts say the transparency bill has been stripped of two of its most critical provisions. The Clear Labels Act was introduced earlier this year by Sens. Rick Scott,…
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
HTML “A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate Vote Landmark legislation designed to alert consumers to where their drugs were made is headed for a full Senate vote, but safety experts…
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
medical distributors and the retailers don’t want to make sure that they supply the highest-quality product?” In a joint press release, Scott and Gillibrand praised the bill’s progress in the Senate, calling it a “massive win for consumer…
- Tier 1 — Primary sourceClear Labels Act Would Require Manufacturing Locations on Prescription Drug Labels — ProPublica
“Every American deserves honesty and transparency about what they are putting into their bodies,” Sen. Rick Scott, R-Fla., said. Kevin Dietsch/Getty Images Rx Roulette The Clear Labels Act Would Change What You Know About Your Prescription…
- Tier 1 — Primary sourceClear Labels Act Would Require Manufacturing Locations on Prescription Drug Labels — ProPublica
key ingredients. ProPublica described this lack of transparency — and how it was enabled by the Food and Drug Administration — in a series of stories that found the agency had quietly allowed troubled foreign drugmakers to continue selling…
- Tier 1 — Primary sourceClear Labels Act Would Require Manufacturing Locations on Prescription Drug Labels — ProPublica
hearing last week, members of the Senate Special Committee on Aging criticized manufacturers for routinely concealing the locations of their drugmaking plants as well as the suppliers that provide key ingredients. ProPublica described this…
Limitations
All evidence comes from the same news outlet (ProPublica); no additional independent sources were provided to corroborate the introduction date.
- Last verified:
- Sep 27, 2026, 4:24 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate VoteProPublica · Naisha Roy